Clinical Trials
442
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (332 trials with phase data)• Click on a phase to view related trials
RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
- Conditions
- HER2 + Breast Cancer
- Interventions
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-15
- Target Recruit Count
- 74
- Registration Number
- NCT07065435
- Locations
- 🇨🇳
The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy
- Conditions
- Gastric Cancer
- First Posted Date
- 2025-07-09
- Last Posted Date
- 2025-07-09
- Target Recruit Count
- 30
- Registration Number
- NCT07056010
- Locations
- 🇨🇳
First Affiliated Hospital of Nanjing Medical Unviersity, Nanjing, Jiangsu, China
Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial
- Conditions
- Gastric Cancer Stage III
- Interventions
- Dietary Supplement: Omega-3 SupplementationDrug: Neoadjuvant Immunotherapy
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Target Recruit Count
- 80
- Registration Number
- NCT07050524
- Locations
- 🇨🇳
First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
The Risk Factors Related to Rupture Flow-related Aneurysms in Posterior AVM
- Conditions
- Arteriovenous Malformation of Central Nervous SystemAneurysm, RupturedAneurysm CerebralAneurysmatic Subarachnoid Haemorrhage
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Target Recruit Count
- 200
- Registration Number
- NCT07050381
- Locations
- 🇨🇳
Jiangsu Province Hospital, Nanjing, Jiangsu, China
🇨🇳the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology
- Conditions
- Blastocyst IVFFertility IssuesEmbryo Culture
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Target Recruit Count
- 980
- Registration Number
- NCT07050537
- Locations
- 🇨🇳
The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳Changzhou Maternal And Child Health Care Hospital, Changzhou, Jiangsu, China
🇨🇳Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 89
- Next